D. M. Adcock and R. Gosselin, Direct oral anticoagulants (DOACs) in the laboratory: 2015 review, Thromb. Res, vol.136, pp.7-12, 2015.

S. J. Ahn, J. Anrather, N. Nishimura, and C. B. Schaffer, Diverse inflammatory response after cerebral microbleeds includes coordinated microglial migration and proliferation, 2018.

M. Antunes and G. Biala, The novel object recognition memory: neurobiology, test procedure, and its modifications, Cogn. Process, vol.13, pp.93-110, 2012.

E. Barbeau, M. Didic, E. Tramoni, O. Felician, S. Joubert et al., Evaluation of visual recognition memory in MCI patients, Neurology, vol.62, pp.1317-1322, 2004.

A. Barrett, M. Moore, P. Ferrins, P. Thornton, P. Murphy et al., From a direct oral anticoagulant to warfarin: reasons why patients switch. Ir, J. Med. Sci, pp.1-3, 2017.

S. Bergeron, Y. Chen, F. Auger, J. Deguil, N. Durieux et al., Role of cortical microbleeds in cognitive impairment: in vivo behavioral and imaging characterization of a novel murine model, J. Cereb. Blood Flow Metab, 2018.

M. Brainin, J. Tuomilehto, W. Heiss, N. M. Bornstein, P. M. Bath et al., Poststroke cognitive decline: an update and perspectives for clinical research, Eur. J. Neurol, vol.22, pp.13-16, 2015.

D. Bulters, B. Gaastra, A. Zolnourian, S. Alexander, D. Ren et al., Haemoglobin scavenging in intracranial bleeding: biology and clinical implications, Nat. Rev. Neurol, vol.14, p.416, 2018.

C. Cordonnier, Brain microbleeds, Pract Neurol, vol.10, pp.94-100, 2010.

J. De-reuck, V. Deramecourt, C. Cordonnier, D. Leys, F. Pasquier et al., Prevalence of small cerebral bleeds in patients with a neurodegenerative dementia: a neuropathological study, J. Neurol. Sci, vol.300, pp.63-66, 2011.

X. Delavenne, S. Laporte, and P. Mismetti, New oral anticoagulants: pharmacological data to know for clinical practice, Rev. Med. Suisse, vol.10, pp.319-324, 2014.

J. Ding, S. Sigurðsson, P. V. Jónsson, G. Eiriksdottir, O. Meirelles et al., Neuropharmacology, vol.155, pp.162-172, 2019.

O. L. Lopez, M. A. Van-buchem, V. Gudnason, and L. J. Launer, Space and location of cerebral microbleeds, cognitive decline, and dementia in the community, Neurology, vol.88, pp.2089-2097, 2017.

E. S. Etten, . Van, E. Auriel, K. E. Haley, A. M. Ayres et al., Incidence of symptomatic hemorrhage in patients with lobar microbleeds, Stroke, vol.45, pp.2280-2285, 2014.

S. M. Greenberg, M. W. Vernooij, C. Cordonnier, A. Viswanathan, R. A. Salman et al., Cerebral microbleeds: a field guide to their detection and interpretation, Lancet Neurol, vol.8, pp.165-174, 2009.

M. Haddad, V. Beray-berthat, B. Coqueran, B. Palmier, C. Szabo et al., Reduction of hemorrhagic transformation by PJ34, a poly(ADPribose)polymerase inhibitor, after permanent focal cerebral ischemia in mice, Eur. J. Pharmacol, vol.588, pp.52-57, 2008.

N. Hidaka, K. Suemaru, B. Li, and H. Araki, Effects of repeated electroconvulsive seizures on spontaneous alternation behavior and locomotor activity in rats, Biol. Pharm. Bull, vol.31, pp.1928-1932, 2008.

S. Hilal, V. Mok, Y. C. Youn, A. Wong, M. K. Ikram et al., Prevalence, risk factors and consequences of cerebral small vessel diseases: data from three Asian countries, J. Neurol. Neurosurg. Psychiatry, vol.88, pp.669-674, 2017.

S. S. Jambhekar and P. Breen, Cyclodextrins in pharmaceutical formulations I: structure and physicochemical properties, formation of complexes, and types of complex, Drug Discov. Today, vol.21, pp.356-362, 2016.

S. Kono, T. Yamashita, K. Deguchi, Y. Omote, T. Yunoki et al., Rivaroxaban and apixaban reduce hemorrhagic transformation after thrombolysis by protection of neurovascular unit in rat, Stroke, vol.45, pp.2404-2410, 2014.

Y. Liu, Y. Dong, P. Lyu, W. Chen, and R. Li, Hypertension-induced cerebral small vessel disease leading to cognitive impairment, Chin Med J (Engl), vol.131, pp.615-619, 2018.

G. Livingston, A. Sommerlad, V. Orgeta, S. G. Costafreda, J. Huntley et al., Dementia prevention, intervention, and care, The Lancet, vol.390, pp.2673-2734, 2017.

M. Marinescu, L. Sun, M. Fatar, A. Neubauer, L. Schad et al., Cerebral microbleeds in murine amyloid angiopathy: natural course and anticoagulant effects, Stroke, vol.48, pp.2248-2254, 2017.

M. Marinescu, L. Sun, M. Fatar, A. Neubauer, L. Schad et al., Cerebral microbleeds in murine amyloid angiopathy: natural course and anticoagulant effects, Stroke, vol.48, pp.2248-2254, 2017.

V. Monnaert, S. Tilloy, H. Bricout, L. Fenart, R. Cecchelli et al., Behavior of ?-, ?-, and ?-cyclodextrins and their derivatives on an in vitro model of blood-brain barrier, J. Pharmacol. Exp. Ther, vol.310, pp.745-751, 2004.
URL : https://hal.archives-ouvertes.fr/hal-00537883

S. Moulin, J. Labreuche, S. Bombois, C. Rossi, G. Boulouis et al., Dementia risk after spontaneous intracerebral haemorrhage: a prospective cohort study, Lancet Neurol, vol.15, pp.820-829, 2016.

M. Paradise, A. Seruga, J. D. Crawford, J. Chaganti, A. Thalamuthu et al., The relationship of cerebral microbleeds to cognition and incident dementia in non-demented older individuals, Brain Imaging Behav, 2018.

*. Participants and T. H. , Basic and translational research in intracerebral hemorrhage: limitations, priorities, and recommendations, HEADS) R, vol.49, pp.1308-1314, 2018.

M. M. Poels, M. A. Ikram, A. Van-der-lugt, A. Hofman, G. P. Krestin et al., Incidence of cerebral microbleeds in the general population: the rotterdam scan study, Stroke, vol.42, pp.656-661, 2011.

A. Y. Shih, H. I. Hyacinth, D. A. Hartmann, S. J. Veluw, and . Van, Rodent models of cerebral microinfarct and microhemorrhage, Stroke, vol.49, pp.803-810, 2018.

E. E. Smith, G. Saposnik, G. J. Biessels, F. N. Doubal, M. Fornage et al., American Heart Association Stroke Council; Council on Cardiovascular Radiology and Intervention

, Prevention of stroke in patients with silent cerebrovascular disease: a scientific statement for healthcare professionals from the American heart association/American stroke association, Stroke, vol.48, pp.44-71, 2017.

A. Stemer, B. Ouyang, V. H. Lee, and S. Prabhakaran, Prevalence and risk factors for multiple simultaneous intracerebral hemorrhages, CED, vol.30, pp.302-307, 2010.

L. Sun, W. Zhou, R. Ploen, M. Zorn, and R. Veltkamp, Anticoagulation with dabigatran does not increase secondary intracerebral haemorrhage after thrombolysis in experimental cerebral ischaemia, Thromb. Haemost, vol.110, pp.153-161, 2013.

P. Toth, S. Tarantini, Z. Springo, Z. Tucsek, T. Gautam et al., Aging exacerbates hypertensioninduced cerebral microhemorrhages in mice: role of resveratrol treatment in vasoprotection, Aging Cell, vol.14, pp.400-408, 2015.

S. J. Van-veluw, G. J. Biessels, C. J. Klijn, and A. J. Rozemuller, Heterogeneous histopathology of cortical microbleeds in cerebral amyloid angiopathy, Neurology, vol.86, pp.867-871, 2016.

S. J. Veluw, . Van, H. J. Kuijf, A. Charidimou, A. Viswanathan et al., Reduced vascular amyloid burden at microhemorrhage sites in cerebral amyloid angiopathy, Acta Neuropathol, pp.1-7, 2016.

S. J. Veluw, . Van, A. Lauer, A. Charidimou, N. Bounemia et al., Evolution of DWI lesions in cerebral amyloid angiopathy: evidence for ischemia, Neurology, vol.89, pp.2136-2142, 2017.

D. Wilson, H. R. Jäger, and D. J. Werring, Anticoagulation for atrial fibrillation in patients with cerebral microbleeds, Curr. Atheroscler. Rep, vol.17, 2015.

R. Wu, C. Feng, Y. Xu, T. Hua, X. Liu et al., Late-onset depression in the absence of stroke: associated with silent brain infarctions, microbleeds and lesion locations, Int. J. Med. Sci, vol.11, pp.587-592, 2014.